Skip to main content
Top

Cancer Causes & Control

Issue 7/2000

Content (12 Articles)

Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men

Elizabeth A. Platz, Walter C. Willett, Graham A. Colditz, Eric B. Rimm, Donna Spiegelman, Edward Giovannucci

Subsite-specific risk factors for hypopharyngeal and esophageal cancer (Japan)

T. Takezaki, M. Shinoda, S. Hatooka, Y. Hasegawa, S. Nakamura, K. Hirose, M. Inoue, N. Hamajima, T. Kuroishi, H. Matsuura, K. Tajima

Employment as butcher and cancer risk in a record-linkage study from Sweden

Paolo Boffetta, Gloria Gridley, Per Gustavsson, Paul Brennan, Aaron Blair, Anna Mia Ekström, Joseph F. Fraumeni

Parental occupational exposures and risk of neuroblastoma: a case–control study (United States)

Mia A. Kerr, Philip C. Nasca, Kenneth A. Mundt, Arthur M. Michalek, Mark S. Baptiste, Martin C. Mahoney

Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States)

Celine M. Vachon, Christopher C. Kuni, Kristin Anderson, V. Elving Anderson, Thomas A. Sellers

Internet tobacco sales

Laurie Fisher

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine